L'intérêt à découvert pour Ten-League International donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Ten-League International. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Ten-League International (NASDAQ:TLIH) Stock, Rapport sur les intérêts à découvert

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.

<p>Fomento Economico (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FMX#NYSE">FMX</a>) &nbsp;Q2 Net majority income per FEMSA ADS $0.42 Up From $1.93 YoY, Total Revenues $10.837B Down From $11.539B YoY</p>


Earnings

Earnings Misses

News

Fomento Economico Mexicano S.A.B. De C.V.

Fomento Economico Q2 Net majority income per FEMSA ADS $0.42 Down From $1.93 YoY, Total Revenues $10.837B Down From $11.539B YoY

WIIM

MCVT

Mill City Ventures shares are trading higher after the company announced a $450 million private placement to build a crypto treasury reserve.

<p>Barclays  analyst Jared Shaw   maintains Associated Banc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASB#NYSE">ASB</a>) with a Equal-Weight and raises the price target from $28 to $30.</p>


Price Target

Analyst Ratings

Barclays Maintains Equal-Weight on Associated Banc, Raises Price Target to $30

<p><i><strong>Skechers Believes Lawsuit Is Baseless and Represents a Blatant Attempt to Have Courts Interfere Where Consumers Have Already Spoken</strong></i></p>
<p>Skechers USA, Inc. ("Skechers"), the Comfort Technology Company and leader in hands-free footwear technology, announced today that it will vigorously defend the patent suit filed in Texas federal court against Skechers by Kizik Design, LLC ("Kizik") alleging,in essence, that the entire line of Skechers Hands Free Slip-ins&#xAE; ("Slip-ins") infringe Kizik's patents. The Company believes that Kizik's allegations are baseless.</p>
<p>As owners of a vast portfolio of intellectual property, Skechers respects the rights of others. Kizik's complaint is based on the assertion that Kizik created the hands-free footwear category and is the only company that can legally use that century-old idea. Contrary to Kizik's false assertion that Skechers patents have been rejected, Skechers has developed its own unique Slip-ins technology and has obtained more than 140 utility and design patents worldwide, including in the United States, and has vigilantly enforced its patent rights, resulting in numerous judgements, injunctions and settlements around the world.</p>


Legal

Skechers Calls Kizik Patent Lawsuit Baseless, Vows To Defend Hands-Free Slip-ins Technology In Court

XPOF

Xponential Fitness Finalizes Divestiture Of CycleBar And Rumble To Extraordinary Brands; Terms Not Disclosed

CRVO

CervoMed shares are trading higher after the company announced results from its Phase 2 RewinD-LB trial.

<p>Morgan Stanley  analyst Dillon Cumming   maintains Westinghouse Air Brake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAB#NYSE">WAB</a>) with a Overweight and raises the price target from $220 to $226.</p>


Morgan Stanley Maintains Overweight on Westinghouse Air Brake, Raises Price Target to $226

<p><i>New contract expands cybersecurity portfolio within Department of Defense to support operational readiness and continued innovation</i></p>
<p><a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fmaximus.com&amp;esheet=54297050&amp;newsitemid=20250728480800&amp;lan=en-US&amp;anchor=Maximus&amp;index=1&amp;md5=44fd34a9d44fc741e2e3a666b96bc765">Maximus</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMS#NYSE">MMS</a>), a leading employer and provider of government services, today announced it has been awarded a new contract by the United States Air Force Life Cycle Management Center (AFLCMC/HNCJ) Cryptologic and Cyber Systems Division (CCSD) to deliver cybersecurity and cloud-based services. Under this award, valued at $77 million, Maximus will support innovation and operational readiness across the Department of Defense (DoD). The contract period of performance is a base year with four one-year option periods with an optional six-month extension.</p>
<p>As the demand for secure, scalable, and resilient systems increases within the Department of Defense, Maximus will deliver cybersecurity, cloud services, and engineering support across multiple security domains.</p>


Contracts

Maximus Secures $77M U.S. Air Force Contract To Expand Cybersecurity And Cloud Services For DoD

SIDU

Sidus Space shares are trading lower after the company announced a $7.5 million public offering.

<p>Morgan Stanley  analyst Angel Castillo   maintains Vulcan Materials (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VMC#NYSE">VMC</a>) with a Equal-Weight and lowers the price target from $303 to $285.</p>


Morgan Stanley Maintains Equal-Weight on Vulcan Materials, Lowers Price Target to $285

<p>Ridgetech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RDGT#NASDAQ">RDGT</a>) reported quarterly earnings of $1.84 per share. This is a 162.8 percent increase over losses of $(2.93) per share from the same period last year.  The company reported $119.972 million in sales this quarter. This is a 3.24 percent decrease over sales of $123.994 million the same period last year.</p>


RDGT

Ridgetech FY EPS $1.84 Up From $(2.93) YoY, Sales $119.972M Down From $123.994M YoY

ADAP

Adaptimmune Therapeutics shares are trading lower after the company announced it has agreed to sell Tecelra and other assets related to its cell therapy products for $55 million.

<p>Barclays  analyst Tom O'Malley   maintains Lam Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LRCX#NASDAQ">LRCX</a>) with a Equal-Weight and raises the price target from $70 to $83.</p>


LRCX

Barclays Maintains Equal-Weight on Lam Research, Raises Price Target to $83

<p>Morgan Stanley  analyst Angel Castillo   maintains United Rentals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/URI#NYSE">URI</a>) with a Overweight and raises the price target from $702 to $955.</p>


Morgan Stanley Maintains Overweight on United Rentals, Raises Price Target to $955

Graphjet Technology shares are trading higher after the company announced that Nasdaq has granted it a continued listing.

<p>Stephens &amp; Co.  analyst Raj Kumar    maintains Ensign Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENSG#NASDAQ">ENSG</a>) with a Overweight and raises the price target from $165 to $170.</p>


ENSG

Stephens & Co. Maintains Overweight on Ensign Group, Raises Price Target to $170

<p>Morgan Stanley  analyst Christyne McGarvey   maintains Ryder System (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/R#NYSE">R</a>) with a Overweight and raises the price target from $175 to $190.</p>


Morgan Stanley Maintains Overweight on Ryder System, Raises Price Target to $190

<h3>Gainers</h3>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>Name</strong></th>
<th align="right"><strong>Price</strong></th>
<th align="right"><strong>Change ($)</strong></th>
<th align="right"><strong>Change (%)</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>)</td>
<td>SPDR Select Sector Fund - Energy Select Sector</td>
<td align="right">87.85</td>
<td align="right">0.75</td>
<td align="right">0.86</td>
<td>98.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLY#NYSE">XLY</a>)</td>
<td>SPDR Select Sector Fund - Consumer Discretionary</td>
<td align="right">226.13</td>
<td align="right">1.26</td>
<td align="right">0.56</td>
<td>8.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>)</td>
<td>SPDR Select Sector Fund - Technology</td>
<td align="right">262.99</td>
<td align="right">1.00</td>
<td align="right">0.38</td>
<td>48.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>)</td>
<td>SPDR Select Sector Fund - Industrial</td>
<td align="right">155.40</td>
<td align="right">0.41</td>
<td align="right">0.26</td>
<td>7.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLC#NYSE">XLC</a>)</td>
<td>The Communication Services Select Sector SPDR Fund</td>
<td align="right">107.85</td>
<td align="right">0.23</td>
<td align="right">0.21</td>
<td>1.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLU#NYSE">XLU</a>)</td>
<td>SPDR Select Sector Fund - Utilities</td>
<td align="right">84.70</td>
<td align="right">0.18</td>
<td align="right">0.21</td>
<td>19.3K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLRE#NYSE">XLRE</a>)</td>
<td>Real Estate Select Sector SPDR Fund (The)</td>
<td align="right">42.85</td>
<td align="right">0.06</td>
<td align="right">0.14</td>
<td>839</td>
</tr>
</tbody>
</table>
<h3>Losers</h3>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>Name</strong></th>
<th align="right"><strong>Price</strong></th>
<th align="right"><strong>Change ($)</strong></th>
<th align="right"><strong>Change (%)</strong></th>
<th><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLP#NYSE">XLP</a>)</td>
<td>SPDR Select Sector Fund - Consumer Staples</td>
<td align="right">81.31</td>
<td align="right">-0.19</td>
<td align="right">-0.24</td>
<td>1.7K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLV#NYSE">XLV</a>)</td>
<td>SPDR Select Sector Fund - Health Care</td>
<td align="right">136.39</td>
<td align="right">-0.09</td>
<td align="right">-0.07</td>
<td>7.0K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLB#NYSE">XLB</a>)</td>
<td>Materials Select Sector SPDR</td>
<td align="right">92.32</td>
<td align="right">-0.05</td>
<td align="right">-0.06</td>
<td>1.2K</td>
</tr>
<tr>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)</td>
<td>SPDR Select Sector Fund - Financial</td>
<td align="right">53.42</td>
<td align="right">-0.02</td>
<td align="right">-0.04</td>
<td>79.0K</td>
</tr>
</tbody>
</table>
<p><a href="https://pro.benzinga.com/?utm_source=insights">Pulled from Benzinga Pro data</a> the above sector movers alert assists traders in understanding macro-level trends and market variations. Traders will look for sector movers providing information on sectors that are over- or under-performing, deriving these results into investing decisions on exchange-traded funds (ETFs) or individual tickers in those sectors. </p>
<p><em>To read more about sector movers, <a href="https://www.benzinga.com/movers">click here</a>.</em> </p>


Sector ETFs

Pre-Market Outlook

Movers

ETFs

XLRE

Select Sector SPDR-Consumer Discretionary

Leading And Lagging Sectors For July 28, 2025

<p>Carlsmed, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARL#NASDAQ">CARL</a>) ("Carlsmed"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the successful completion of the first aprevo&#xAE; cervical procedure on July 14, 2025 by Joseph Osorio, MD, PhD, Chief of Spine Surgery in the Department of Neurological Surgery at UC San Diego (UCSD) Health in San Diego, CA.</p>
<p>The aprevo&#xAE; devices are designed to match the unique anatomical and alignment needs of each patient through Carlsmed's proprietary AI-powered surgical planning platform and digital production system.</p>


Biotech

General

CARL

Carlsmed Announces First Successful AI-Enabled aprevo Cervical Spine Surgery Completed At UC San Diego

Safe Bulkers Agrees For Sale Of MV Pedhoulas Leader At Gross Sale Price Of $12.5M And Forward Delivery Date Between August And October 2025

IPOs

Press Releases

Ten-League International Holdings Limited Announces Pricing of Initial Public Offering

Financing

Ten-League International Holdings Limited Announces Closing of Initial Public Offering

TLIH

Ten-League International Holdings Limited - Ordinary Shares

Comments

Ten-League International

Intérêt court

Ten-League International (NASDAQ:TLIH) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL